Literature DB >> 31585169

The NCATS Pharmaceutical Collection: a 10-year update.

Ruili Huang1, Hu Zhu2, Paul Shinn2, Deborah Ngan2, Lin Ye2, Ashish Thakur2, Gurmit Grewal2, Tongan Zhao2, Noel Southall2, Mathew D Hall2, Anton Simeonov2, Christopher P Austin2.   

Abstract

The National Center for Advancing Translational Sciences (NCATS) Pharmaceutical Collection (NPC), a comprehensive collection of clinically approved drugs, was made a public resource in 2011. Over the past decade, the NPC has been systematically profiled for activity across an array of pathways and disease models, generating an unparalleled amount of data. These data have not only enabled the identification of new repurposing candidates with several in clinical trials, but also uncovered new biological insights into drug targets and disease mechanisms. This retrospective provides an update on the NPC in terms of both successes and lessons learned. We also report our efforts in bringing the NPC up-to-date with drugs approved in recent years. Published by Elsevier Ltd.

Year:  2019        PMID: 31585169     DOI: 10.1016/j.drudis.2019.09.019

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  19 in total

1.  A Genome-Edited ERα-HiBiT Fusion Reporter Cell Line for the Identification of ERα Modulators Via High-Throughput Screening and CETSA.

Authors:  Hunter G Larson; Alexey V Zakharov; Sukumar Sarkar; Shyh-Ming Yang; Ganesha Rai; James M Larner; Anton Simeonov; Natalia J Martinez
Journal:  Assay Drug Dev Technol       Date:  2021-10-14       Impact factor: 1.738

2.  Rottlerin inhibits La Crosse virus-induced encephalitis in mice and blocks release of replicating virus from the Golgi body in neurons.

Authors:  Durbadal Ojha; Clayton W Winkler; Jacqueline M Leung; Tyson A Woods; Catherine Z Chen; Vinod Nair; Katherine Taylor; Charles D Yeh; Gregory J Tawa; Charles L Larson; Wei Zheng; Cathryn L Haigh; Karin E Peterson
Journal:  Nat Microbiol       Date:  2021-10-21       Impact factor: 17.745

3.  NCATS Inxight Drugs: a comprehensive and curated portal for translational research.

Authors:  Vishal B Siramshetty; Ivan Grishagin; Ðắc-Trung Nguyễn; Tyler Peryea; Yulia Skovpen; Oleg Stroganov; Daniel Katzel; Timothy Sheils; Ajit Jadhav; Ewy A Mathé; Noel T Southall
Journal:  Nucleic Acids Res       Date:  2022-01-07       Impact factor: 16.971

4.  Prediction of drug-induced liver injury and cardiotoxicity using chemical structure and in vitro assay data.

Authors:  Lin Ye; Deborah K Ngan; Tuan Xu; Zhichao Liu; Jinghua Zhao; Srilatha Sakamuru; Li Zhang; Tongan Zhao; Menghang Xia; Anton Simeonov; Ruili Huang
Journal:  Toxicol Appl Pharmacol       Date:  2022-09-20       Impact factor: 4.460

Review 5.  Retro Drug Design: From Target Properties to Molecular Structures.

Authors:  Yuhong Wang; Sam Michael; Shyh-Ming Yang; Ruili Huang; Kennie Cruz-Gutierrez; Yaqing Zhang; Jinghua Zhao; Menghang Xia; Paul Shinn; Hongmao Sun
Journal:  J Chem Inf Model       Date:  2022-06-02       Impact factor: 6.162

6.  GPC1-Targeted Immunotoxins Inhibit Pancreatic Tumor Growth in Mice via Depletion of Short-lived GPC1 and Downregulation of Wnt Signaling.

Authors:  Jiajia Pan; Nan Li; Alex Renn; Hu Zhu; Lu Chen; Min Shen; Matthew D Hall; Min Qian; Ira Pastan; Mitchell Ho
Journal:  Mol Cancer Ther       Date:  2022-06-01       Impact factor: 6.009

7.  Identification of Small Molecule Inhibitors of a Mir155 Transcriptional Reporter in Th17 Cells.

Authors:  Anju Singh; Myagmarjav Dashynam; Bryan Chim; Thelma M Escobar; Xiuhuai Liu; Xin Hu; Samarjit Patnaik; Xin Xu; Noel Southall; Juan Marugan; Ajit Jadhav; Vanja Lazarevic; Stefan A Muljo; Marc Ferrer
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.996

8.  Targeting ACE2-RBD interaction as a platform for COVID19 therapeutics: Development and drug repurposing screen of an AlphaLISA proximity assay.

Authors:  Quinlin M Hanson; Kelli M Wilson; Min Shen; Zina Itkin; Richard T Eastman; Paul Shinn; Matthew D Hall
Journal:  bioRxiv       Date:  2020-06-16

9.  Predictive Models to Identify Small Molecule Activators and Inhibitors of Opioid Receptors.

Authors:  Srilatha Sakamuru; Jinghua Zhao; Menghang Xia; Huixiao Hong; Anton Simeonov; Iosif Vaisman; Ruili Huang
Journal:  J Chem Inf Model       Date:  2021-05-28       Impact factor: 6.162

10.  Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2.

Authors:  Catherine Z Chen; Paul Shinn; Zina Itkin; Richard T Eastman; Robert Bostwick; Lynn Rasmussen; Ruili Huang; Min Shen; Xin Hu; Kelli M Wilson; Brianna Brooks; Hui Guo; Tongan Zhao; Carleen Klump-Thomas; Anton Simeonov; Samuel G Michael; Donald C Lo; Matthew D Hall; Wei Zheng
Journal:  bioRxiv       Date:  2020-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.